chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He was having severe chest pain 10/10; Shortness of breath; Neck pain that radiated through his spine; This is a spontaneous report from a contactable physician (patients mother). A 15-years-old male patient received bnt162b2 (BNT162B2, formulation: Solution for injection), dose 1 via an unspecified route of administration on 15May2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 16May2021, the next night (second day) he was having severe chest pain 10/10, shortness of breath, neck pain that radiated through his spine, pulse oxygen level 98 percent and his heart rate was fine. Patient received the first dose of the covid vaccine on Saturday, and Sunday is when the severe symptoms started. Caller stated she gave him tylenol and then he was fine. On the third day symptoms improved. By Monday, patient was better. Caller stated her sons next dose is scheduled 05Jun2021. Reporter read new reports about myocarditis. Reporter does not know who to contact to figure out if patient should get the second dose of the covid vaccine. Reporter heard that after the second dose of the covid vaccine, symptoms get worse. Caller stated she had reported on V-safety. Reporter declined to complete a safety report. Reporter has already reported through VAERS. The outcome of events was recovered. Unable to clarify details provided or gather additional information.  Caller notified that medical advice is not able to be provided but may have resources to help answer questions. Caller was provided with phone number of (number withheld), option 3, and hours of operation of Monday through Friday, 8AM to 8PM, Saturday and Sunday 9AM to 3PM for COVID-19 vaccine inquiries, prior to attempted warm transfer. Unable to warm transfer due to high call volume. Caller agreed to cold transfer.  Information on the lot/batch number has been requested.
TDAP administered subcutaneously on 11-16-2011. Site evaluated 11-19-2011 in follow-up and no problems noted. Pt contacted 12-2-2011 in follow-up, she reports no long-term effects.
Dizziness almost immediately after the shot, High heart rate and blood pressure, Difficulties to breath, and Disorientation. No treatment.  All the symptoms dissapeared after 7 hours.
feeling sick; suspected sinus infection; cough; wheezing; sluggish; no appetite; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (feeling sick), SINUSITIS (suspected sinus infection), COUGH (cough), WHEEZING (wheezing) and SLUGGISHNESS (sluggish) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma (prior medical history of asthma).    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced MALAISE (feeling sick), SINUSITIS (suspected sinus infection), COUGH (cough), WHEEZING (wheezing), SLUGGISHNESS (sluggish) and DECREASED APPETITE (no appetite). The patient was treated with PREDNISONE at a dose of 1 dosage form. At the time of the report, MALAISE (feeling sick) had resolved and SINUSITIS (suspected sinus infection), COUGH (cough), WHEEZING (wheezing), SLUGGISHNESS (sluggish) and DECREASED APPETITE (no appetite) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, SARS-CoV-2 test: negative (Negative) COVID test Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included antibiotics, cough medicine, and prednisone. No concomitant medication details provided.   This case was linked to MOD-2021-066278 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: Follow up received on 02-APR-2021 contains Non significant information.
Pt woke up from sleeping and noticed his lips were stinging and saw they were swollen. Applied chapstick but reported bottom lip still swollen. The patient denies consuming new foods, or medications. The patient denies rash, itch, vomiting, or wheezing.  Onset  01:00 AM 3/26/2021 ; Timing  persistent ; Location  bottom lip ; Radiation  denies Quality  swollen ; Severity  moderate ; Associated Symptoms  "Weird" sensation swallowing (and "throat pain/scratchy") Modifying Factors  denies ; Treatment Before Arrival  Benadryl 50mg (has helped)  Treated in ED with EPI pen, Pepcid, Solumedrol, and NS infusion.
pt recv vax & presented w/ 6x6 area of swelling & fever 101;this is 1 of 3 pt from the same site & lot# to exp these rxn;
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with ZOSTAVAX (route, site of administration and lot# not reported). Concomitant Medication included "unspecified steroids". On an unknown date, the patient developed "redness and itchiness" at the injection site, lasting for an unspecified duration of time. The pharmacist did not indicate the present status of the patient. Hence, the outcome of injection site erythema and injection site pruritus was unknown. No additional information was provided. Causality was not assessed by the reporter. Product quality complaint was not filed. Additional information has been requested.
This is a spontaneous report from a non-contactable consumer via a non-clinical study program. A patient of unspecified age and gender received TRUMENBA at single dose, on unknown date. Medical history and concomitant medications were not provided. The patient got a rash on an unknown date after vaccine injection. Event outcome was unknown. No follow up attempts possible. No further information expected.
Pt recvd 3 doses of Engerix-B vax & it was determined DEC91 that pt was a non-responder;
Back paint, fever, and urinary tract infections symptoms.  Urticaria over trunk of body and left arm.  Sought medical attention at emergency room.  Topical lotion to rash.  Levaquin for pyelonephritis.
5-6 days, post vax, left arm was swollen and red, hot, burning and itchy and discolored. Had a low-grade fever, then aches and pains all over. Then arm was even more sore, swollen and hurt under her arm so she saw a doctor on 3/8/01. Treated with Keflex 500mg. Fever broke on night of 3/8/01.
Client came into the vaccination room with mother, sibling, and interpreter. Writer asked client?s mother for client?s covid19 vaccine card to review date of last covid19 vaccine. Writer asked client?s mother if client tolerated the first vaccine well. Client?s mother reported, ?yes.? Writer reviewed the front and the back page of the covid19 children?s consent form with client?s mother via use of the interpreter. After all questions were answered, writer administered client?s covid19 vaccination. Writer filled out client?s covid19 vaccination card with client?s second dose of Peds. Pfizer 0.2 mL vaccine. Writer completed the same for client?s sibling. Client, mother, sibling, and interpreter sent to waiting area to wait the 15 minutes as suggested due to no adverse reactions after their first covid19 vaccine and no underlying concerns. Writer provided the covid19 signed consent form to enter into database. Staff member asked writer ?Are we giving booster doses to children?? Writer asked, ?No, what are you talking about?? Reported, ?This child received a second dose on 12/09/2021.? Writer went to lobby and spoke with client?s mother via interpreter, Writer took both clients and siblings covid19 cards back to writer?s office and looked both children up in database. Client and sibling received their first covid19 vaccine together and both were documented in database, on consent forms, and on their covid19 cards. Writer looked in database to find that the client had received a 2nd covid19 vaccine on 12/09/21 which was documented in database, but not on client?s card. Writer went through the on file parent consent forms and foudn client?s covid19 vaccine consent for 12/09/2021. Writer immediately reported the incident to supervisor. Supervisor and writer took client?s mother and interpreter into vaccination room and spoke with them. Client?s mother had no memory of bringing the client into the clinic for a second dose, she stated she always brought the two children in together. She stated that she has seven children and sometimes her memory can be a bit off. Error was explained to client?s mother with use of the interpreter and signs and symptoms to monitor for.
Less than 3 weeks after my vaccination, I started getting a blurry spot in the middle of my left eye. It eventually turned into a grey floating blob, and I went to see my ophthalmologist, who said it would go away. I gave it a couple days and it got worse. It resulted in my blindness in my left eye.  I went to see a retinal specialist, who diagnosed me with optic neuropathy -- and I sought a second opinion from a neuro-ophthalmologist, who diagnosed me with optic neuritis affecting my myelin sheath.
First night sleeplessness; 36 hours generally feeling crappy; 6 days tenderness at injection site.
THE PATIENT CAME IN FOR THE 2ND DOSE OF THEIR COVID VACCINE. THEY WERE GIVEN PFIZER. IT WAS DISCOVERED AFTER ADMIN THAT THE FIRST DOSE WAS MODERNA. THE PATIENT WAS TOLD ABOUT THE MISTAKE AND WAS MONITORED FOR THE USUAL TIME AFTER THE SHOT FOR ADVERSE EVENTS. NO ADVERSE EVENTS OCCURRED AT HER TIME AT THE PHARMACY.
Information has been received from a county health registered nurse concerning a 7 year old male who on 02-OCT-2002 was vaccinated with varicella virus vaccine live (Oka/Merck). On 24-MAR-2007 the patient developed varicella < 50 lesions. The nurse reported that an outbreak of varicella had taken place in the local school district in April 2007, and this student was identified during the county health investigation. An immunization clinic was conducted in the school where students received a second dose of varicella virus vaccine live (Oka/Merck). This is one of 28 reports received from the the same source. No further information is available.
The evening of administration of vax pt exp malaise & h/a; The next day sx of severe nausea & h/a occurred, w/sl body aches & vertigo; by the third day sx subsided & pt improved;
This spontaneous report as received from a pharmacist refers to a patient of unknown age who was vaccinated with PNEUMOVAX23 (dose and lot # not reported) IM on 17-SEP-2010 and on 17-SEP-2012 was vaccinated again after 1-2 years with another dose of PNEUMOVAX23 (dose and lot # not reported). No known adverse effects were reported. Additional information has been requested.
-whole left Arm, Rash, may be shingles -Painful & Itching Rash -More than 2 weeks & still not getting Better.
2-3 hours post vaccination pain in L axillary area then continued with redness and swollen.  ROM is decreased.  Cannot pick up anything with that arm.
Patient experienced tingling then swelling of left the left cheek, same side of body vaccine was administered. No signs of anaphylaxis, patient could breath normally. Patient did not experience signs of facial paralysis (ruled out acute bells palsy). Swelling lasted multiple days. Patient took Benadryl and ibuprofen for 2 days at home. Patient called PCP office and they provided no insight. Potential hypothesis is swollen lymph node?
This case was reported by a physician via call center representative and described the occurrence of injected limb mobility decreased in a 17-year-old female patient who received BEXSERO (batch number 154101A, expiry date 30th May 2017). Concomitant products included HPV vaccine and Men ACWY-CRM NVS (potential MENVEO). On 15th July 2016, the patient received BEXSERO .5 ml. On 15th July 2016, immediately after receiving BEXSERO, the patient experienced injected limb mobility decreased (serious criteria disability), fatigue (serious criteria disability), appetite lost (serious criteria disability) and weight loss (serious criteria disability). In July 2016, the outcome of the injected limb mobility decreased was recovered/resolved. On an unknown date, the outcome of the fatigue, appetite lost and weight loss were recovering/resolving. The reporter considered the injected limb mobility decreased, fatigue, appetite lost and weight loss to be almost certainly related to BEXSERO. Additional details were provided as follows: This case was previously reported to a doctor. The doctor reported that the patient experienced inability to raise injected arm (right deltoid) immediately following BEXSERO vaccination for 1 week. On the same day, the patient also experienced fatigue, loss of appetite and weight loss of 6 pounds for 2 weeks after vaccination and they were ongoing at the time of reporting.
had both shots, got shingles/Suspected vaccination failure; shingles; got covid; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient had shingles four times). Concurrent medical conditions included hepatitis c (The patient had hepatitis C since 1987).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and covid-19. On an unknown date, the outcome of the vaccination failure, shingles and covid-19 were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and covid-19 to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 31-JUL-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient had shingles fourth times and finally had both shingles shots but after he/she got covid and shingles again. The patient had hepatitis C since 1987. The patient's doctor figured that, it was because he/she had a virus living in his/her for so many years.  The patient stated that, they were surprised and got them again.  The patient further stated that, best of luck to everyone else though. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Moderna COVID?19 Vaccine EUA  Patient received COVID-19 vaccine booster dose on 4/4/2022. No symptoms or adverse events noted during administration and observation.  No adverse events reported by the patient to date.  On 5/4/2022 discovered that dose administered is past the expiration or beyond-use date.  Manufacturer contacted to report event and  to obtain re-vaccination guidance.
Patient experienced redness, tenderness and swelling from the Fluzone injection site traveling down her arm toward her inner arm
4/28/21 Leg pain. 7/22/21 Pain in feet and hands. 8/23/21 Pain in right side ovary area/hip. 8/24/21 Also now having cold spots in feet and ankles.(have since subsided for the most part) 10/5/21 Now feel pulse (bounding pulse) in feet. 11/28/21 Bounding pulse is now in feet and has spread to calves.  All of these symptoms have come and gone, but now for the last 4 weeks or so they've been more consistent.
On 9/11/01, pt's left leg was slightly swollen and red. On 9/12/01, pt had increasing swelling and redness and knee feels hot. Pt was given antihistamine and steroid. On 9/13/01, the pt is doing better today and has decreased swelling and redness.
Information has been received from a nurse concerning a 14 year old female who on 17-JUN-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot no. not reported) 0.5ml via intramuscular route. Site of injection was not reported. The patient experienced syncope right after receiving initial dose of GARDASIL vaccine (yeast). The patient was placed in a wheel chair and taken to a room in office. Vital signs demonstrated hypotension and bradycardia. The patient passed out several more times during this period in office. The patient was sent to hospital ER in ambulance, but was not admitted as In-Patient. On 18-JUN-2008, the patient recovered from syncope, hypotension, bradycardia and passed out. On the same day, the patient still had a headache. Additional information has been requested.
This spontaneous report was received from a licensed vocational nurse regarding unspecified patients of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of M-M-R II (dose and route were not reported, Lot # K005175 with expiration date 10-OCT-2016  or lot # K020188 with expiration date 22-OCT-2016). There were not adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Dull continuous pain in left arm where shot was administered; Painful to lift arm above head; too weak to hold things.; Felt pain in veins in arm and muscle, down to my finger; Felt pain in veins in arm and muscle, down to my finger; Felt pain in veins in arm and muscle, down to my finger; Some chest pain on the left side; This is a spontaneous report from a contactable consumer reported for herself. A 27-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Batch/Lot number was not reported) via an unspecified route of administration in arm left on 25Feb2021 as 1st dose, single dose for COVID-19 immunisation. Medical history included as none. Concomitant medications included sertraline (SERTRALINE) 100 mg taken for an unspecified indication, start and stop date were not reported in two weeks. No other vaccine in four weeks. No covid prior vaccination and tested covid post vaccination known allergies were none. On 26Feb2021 12:00 AM, patient experienced dull continuous pain in left arm where shot was administered, painful to lift arm above head and too weak to hold things, felt pain in veins in arm and muscle, down to my fingers. Some chest pain on the left side happened a few days later. The patient underwent lab tests and procedures which included sars-cov-2 test resulted as negative on an unspecified date. Covid test type post vaccination was nasal swab. No treatment received. The clinical outcome of the event was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Instant and severe diarrhea; White blood cells indicated inflammation.; Heavy legs at night; This is a spontaneous report from a contactable consumer (patient). A 51-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number, Expiry date: not reported) via an unspecified route of administration, administered in arm left on 14Apr2021 at 16:00 (age at vaccination 51-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number and Expiry date: not reported) via an unspecified route of administration, administered in arm left on 22Apr2021 at 16:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included birth control from an unknown date and unknown if ongoing (patient received birth control pills other medications in two weeks). The patient had no known allergies. The patient concomitant medications were not reported. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 15Apr2021 16:00, the patient had experienced instant and severe diarrhoea started about 24 hours after second injection. It had not stopped for over six weeks. I went to the doctor at four weeks and did bloodwork and provided stool sample. White blood cells indicated inflammation. I also had heavy legs at night which was also new and very scary. The patient did not receive treatment for the adverse event. The adverse event resulted in doctor or other healthcare professional office/clinic visit. On an unspecified date 2021, the patient underwent lab tests and procedures which included blood test: unknown result, stool analysis: unknown result. The outcome of events was not recovered.  Follow-up activities closed. Batch/lot number not available for [Vaccine BNT162B2].
Information has been received from a nurse practitioner concerning a teenage female with no medical history and no drug allergies, who on 22-APR-2008 was vaccinated IM with a first dose of GARDASIL.  On 25-APR-2008 the patient experienced shortness of breath, elevated pulse, and breathing issues.  The patient was taken to the emergency room but the specifics were unknown.  The patient recovered on an unspecified date.  No product quality complaint was involved.  Additional information has been requested.
She is in misery and every morning when she gets up, she is just hoping she doesn't fall over because her muscles are so contracted; Muscular problems; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown manufacturer.), for Immunization. The following information was reported: MUSCLE CONTRACTURE (non-serious), outcome "unknown", described as "She is in misery and every morning when she gets up, she is just hoping she doesn't fall over because her muscles are so contracted"; MUSCLE DISORDER (non-serious), outcome "unknown", described as "Muscular problems".  Additional information: Since the patient had that vaccine second dose patient was experienced a lot of muscular problems. Patient is in misery and every morning when she gets up, she was just hoping she did not fall over because her muscles are so contracted. Patients stated that she would rather take her chances of getting the virus than getting more shots.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Red rash on arm where vaccine was given.  Rash is splotchy and bumpy and has spread down from vaccine site.  Very hot to touch.  Itchy and painful to touch.  Started night after vaccine and got larger  2 days after.  Also have pain in armpit on right side.
Patient received pfizer vaccine, sitting for observation for 15min and observed by next patient, who alerted pharmacist, that he passed out, dropped phone/papers, and shakes. Pharmacist about to administer epipen but he regained consciousness in seconds, alert and stated dizzy, drank water given to him. 911 called and paramedic came to check him. BP is low, he's brought out in strecher to hospital(?) for evaluation. Wife came to pharmacy later to inquire since she got call from him being in hospital for observation. Wife stated that he is nervous about needles, vaccination
loss of conscience @ window-hit head on floor;pulse 64 (@ 440PM BP 130/78 call to MD recommended eval, pt taken to urgent care;330AM vomiting/h/a;